US cancer mortality continues decline but incidence rises slightly for womenOctober 05, 2005Overall rates of cancer death for both men and women have declined in the United States, and cancer incidence has remained stable among men. However, overall cancer incidence among women has increased slightly, according to a special article that appears in the October 5 issue of the Journal of the National Cancer Institute. This annual report to the nation, which this year includes statistics on the 15 most common cancers in the five major racial and ethnic populations in the United States for 1995 to 2002 and features a section on trends in the delivery and determinants of cancer treatment, is a collaborative effort by the National Cancer Institute (NCI), the Centers for Disease Control and Prevention (CDC), the North American Association of Central Cancer Registries (NAACCR), and the American Cancer Society. To produce this report, the authors, led by Brenda K. Edwards, Ph.D., of the National Cancer Institute, gathered data on cancer incidence and deaths from the NCI, CDC, and NAACCR. They also derived population-based treatment data from the Surveillance, Epidemiology, and End Results (SEER) program, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Among men, cancer incidence remained stable from 1995 through 2002, and the overall rate of cancer death decreased by 1.5% per year from 1993 through 2002. Incidence of melanoma and cancers of the esophagus, kidney, and prostate increased, but incidence of cancers of the colon and rectum, larynx, lung, oral cavity, and stomach decreased. Death rates decreased for 12 of the 15 most common cancers. Among women, cancer incidence increased by 0.3% per year from 1987 through 2002, but the overall rate of cancer death decreased by 0.8% per year from 1992 through 2002. Incidence of leukemia, non-Hodgkin lymphoma, melanoma, and cancers of the bladder, breast, kidney, and thyroid increased, but incidence of cancers of the cervix, colon and rectum, oral cavity, ovary, and stomach decreased. Death rates decreased for 9 of the 15 most common cancers. One strategy for reducing the number of cancer deaths and improving survival among those diagnosed with cancer is to ensure that evidence-based treatment services are available and accessible, the authors suggest. A review of studies on trends in cancer treatment suggested that because the dissemination of guidelines for cancer treatment is not always rapid and complete, some aspects of recommended treatments-such as the use of radiation therapy after breast-conserving surgery for women with early-stage breast cancer-may not be fully implemented in the community treatment setting. The authors also found some evidence of possible disparities in the patterns of treatment based on patient age at diagnosis, race, and type of health plan as well as geographical variations. "Placing a high priority on continuing [partnerships within the cancer surveillance community], as well as on developments in medical informatics and the electronic medical record, and the adoption of standardized messaging and vocabularies, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention and detection and uniformly high-quality care in all areas and populations of the United States," the authors conclude. Journal of the National Cancer Institute |
|||||||||||||||||||||
| Related Cancer Death Current Events and Cancer Death News Articles Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results. Blood vessels might predict prostate cancer behavior A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? Experts issue call to reconsider screening for breast cancer and prostate cancer Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association." Detecting the undetectable in prostate cancer screening A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. Scientists identify common HPV genotypes in northern India, encourage vaccination Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region. Study in Spain and Romania confirms radon as second leading cause of lung cancer Exposure to radon gas in homes is the second leading cause of lung cancer after smoking, according to a study carried out by researchers from the University of Cantabria and the Babes-Bolyai University in Romania. Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress. Even in a safety net health system, colorectal cancer screening disparities remain Colorectal cancer screening rates are much lower among those in a safety net health system compared to the national average, and the number one predictor of screening is a combination of regular visits and insurance access. More Cancer Death Current Events and Cancer Death News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||